" /> Lung cancer antibody panel:-:Pt:Ser/Plas:-:IA - CISMeF





Preferred Label : Lung cancer antibody panel:-:Pt:Ser/Plas:-:IA;

LOINC status : ACTIVE;

LOINC display name : Lung cancer antibody panel IA;

LOINC long common name : Lung cancer antibody panel - Serum or Plasma by Immunoassay;

LOINC short name : Lung cancer antibody panel SerPl IA;

LOINC description : This panel of terms was developed by, but not limited to, Oncimmune. Elevated levels of the autoantibodies in this panel against lung tumor proteins are present in 40% of lung cancer patients at the time the malignancy is diagnosed. This panel of six autoantibodies is used to assist in the early diagnosis of lung cancer in patients at high risk of developing it, either because of risk factors such as smoking or the presence of a nodule on a CT scan.[PMID: 21733826];

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.